PRESS RELEASE Bethesda.

By offering a specialty pharmacy system, a health system gets the unique opportunity to connect to complex individual populations with life-long diseases at least monthly, developing a much stronger bond with those patients, the article’s authors point out. This provides an increased level of service and client satisfaction, along with a more impressive range of care. – See more at:.. PRESS RELEASE Bethesda, MD—A wave of innovation in specialty medications that caused U.S.For the BEAT-ROP Cooperative Group: Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity Retinopathy of prematurity can be a neovascular retinal disorder of childhood that causes loss of eyesight through macular dragging and retinal detachment.1 The incidence of blindness in infants due to retinopathy of prematurity is relatively low, about 1 case in 820 infants,2 because of good neonatal care and appropriate treatment and screening. The world-wide prevalence of blindness due to retinopathy of prematurity can be 50,000.1 Retinal vascularization about the internal retinal surface area begins at the optic nerve at 16 weeks’ gestation and proceeds anteriorly, achieving the edge of the temporal retina at 40 weeks’ gestation.